RWD comprises various data gathered outside of traditional clinical research settings. This includes electronic health records (EHRs), insurance claims, patient registries and wearable device data.

Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs are coming to market faster than ever. A 2024 analysis of drugs included in this ...

In a world where connectivity and data reign supreme, the internet of things (IoT) has emerged as a groundbreaking technology that’s not just a buzzword, but a tangible reality with impressive ...

The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications alongside ...

Jeffrey Stark, MD, vice president, head of medical immunology, UCB, discusses ongoing clinical trials and the development of real-world data to understand the effectiveness of bimekizumab-bkzx in a ...

Traditionally, AI progress was constrained by one thing above all else: access to data. Not enough volume. Not enough ...

Mayo Clinic clinicians are starting to explore how they might use healthcare-specific large language models – accessed through a generative artificial intelligence chat application – to enhance ...

Digital patient profiles and real-world data enhance oncology trial design, patient recruitment, and reduce trial failure risks. Phesi's platform aligns trial designs with real-world data, minimizing ...

Emulation, simulation, and synthesis represent distinct synthetic-patient paradigms, ranging from reweighted external controls to mechanistic/statistical disease ...

Today’s health care leaders are awash in data. There’s no shortage of organizations collecting, structuring, and licensing massive real-world data sets, each touting millions of de-identified “patient ...